Abstract:Toll-IL-1R (TIR) family members play crucial roles in a variety of defense, inflammatory, injury, and stress responses. Although they have been widely investigated in mammals, little is known about TIRs in ancient vertebrates. In this study, we report a novel double Ig IL-1R related molecule (DIGIRR) from three model fish (Tetraodon nigroviridis, Gasterosteus aculeatus, and Takifugu rubripes), adding a previously unknown homolog to the TIR family. This DIGIRR molecule contains two Ig-like domains in the extracellular region, one Arg-Tyr-mutated TIR domain in the intracellular region, and a unique subcellular distribution within the Golgi apparatus. These characteristics distinguish DIGIRR from other known family members. In vitro injection of DIGIRR into zebrafish embryos dramatically inhibited LPS-induced and IL-1 beta-induced NF-kappa B activation. Moreover, in vivo knockdown of DIGIRR by small interfering RNA significantly promoted the expression of IL-1 beta-stimulated proinflammatory cytokines (IL-6 and IL-1 beta) in DIGIRR-silenced liver and kidney tissues and in leukocytes. These results strongly suggest that DIGIRR is an important negative regulator of LPS-mediated and IL-1 beta-mediated signaling pathways and inflammatory responses. The Arg-Tyr-mutated site disrupted the signal transduction ability of DIGIRR TIR. Evolutionally, we propose a hypothesis that DIGIRR and single Ig IL-1R related molecule (SIGIRR) might originate from a common ancient IL-1R-like molecule that lost one (in DIGIRR) or two (in SIGIRR) extracellular Ig-like domains and intracellular Ser and Arg-Tyr amino acids. DIGIRR might be an evolutionary "transitional molecule" between IL-1R and SIGIRR, representing a shift from a potent receptor to a negative regulator. These results help define the evolutionary history of TIR family members and their associated signaling pathways and mechanisms. The Journal of Immunology, 2011, 187: 2514-2530.

Research Progress on the Negative Regulatory Function of SIGIRR to IL-1R/TLRs Signal Pathway

SIGIRR, a Negative Regulator of Toll-like Receptor–interleukin 1 Receptor Signaling

SIGIRR / TIR8: A Negative Regulator of Toll-IL-1R Signaling

The role of IL-1 related receptor SIGIRR in immune related diseases

Immunomodulation of Interleukin-34 and Its Potential Significance As a Disease Biomarker and Therapeutic Target

SIGIRR Inhibits Interleukin-1 Receptor- and Toll-Like Receptor 4-Mediated Signaling Through Different Mechanisms.

Biological functions and clinical implications of interleukin-34 in inflammatory diseases

Characterization of SIGIRR/IL-1R8 Homolog from Zebrafish Provides New Insights into Its Inhibitory Role in Hepatic Inflammation

The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response.

Discovery of the DIGIRR gene from teleost fish: a novel Toll-IL-1 receptor family member serving as a negative regulator of IL-1 signaling.

The Essential Role Of Single Ig Il-1 Molecule/Toll Il-1r8 In Regulation Immune Response

Negative Effects of SIGIRR on TRAF6 Ubiquitination in Acute Lung Injury In Vitro

The Toll–Interleukin-1 Receptor Member SIGIRR Regulates Colonic Epithelial Homeostasis, Inflammation, and Tumorigenesis

Modulation of Toll–interleukin 1 receptor mediated signaling

Ectopic Expression of SIGIRR in the Colon Ameliorates Colitis in Mice by Downregulating TLR4/NF-κB Overactivation.

SIGIRR attenuates Toll-like receptor 4-mediated immune response in bovine mammary epithelial cells

Negative Regulator IL-1 Receptor 2 (IL-1R2) and Its Roles in Immune Regulation of Autoimmune Diseases

Single Immunoglobulin IL-1 Receptor-Related Protein Attenuates the Lipopolysaccharide-Induced Inflammatory Response in A549 Cells.

Downregulation of TLR4 by Mir-181A Provides Negative Feedback Regulation to Lipopolysaccharide-Induced Inflammation

Transcriptomic Analysis Reveals That IL-1R8/Sigirr is a Novel Macrophage Migration Regulator and Suppresses Macrophage Proliferation Through P38 MAPK Signaling Pathway.

Research progress of B subfamily of leucocyte immunoglobulin-like receptors in inflammation